Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia.

ABSTRACT:

SUBMITTER: Nilsson MS 

PROVIDER: S-EPMC7027927 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature